Orange County NC Website
<br /> <br />Exhibits, page 2 <br />First Aid, peer-based programs, or similar approaches. Training programs may target <br />parents, family members, caregivers, teachers, school staff, peers, neighbors, health or <br />human services professionals, or others in contact with children or adolescents. <br />7. Naloxone distribution. Support programs or organizations that distribute naloxone to <br />persons at risk of overdose or their social networks, such as Syringe Service Programs, <br />post-overdose response teams, programs that provide naloxone to persons upon release <br />from jail or prison, emergency medical service providers or hospital emergency <br />departments that provide naloxone to persons at risk of overdose, or community-based <br />organizations that provide services to people who use drugs. Programs or organizations <br />involved in community distribution of naloxone may, in addition, provide naloxone to <br />first responders. <br />8. Post-overdose response team. Support post-overdose response teams that connect <br />persons who have experienced non-fatal drug overdoses to addiction treatment, recovery <br />support, harm reduction services, primary healthcare, or other services or supports they <br />need to improve their health or well-being. <br />9. Syringe Service Program. Support Syringe Service Programs operated by any <br />governmental or nongovernmental organization authorized by section 90-113.27 of the <br />North Carolina General Statutes that provide syringes, naloxone, or other harm reduction <br />supplies; that dispose of used syringes; that connect clients to prevention, treatment, <br />recovery support, behavioral healthcare, primary healthcare, or other services or supports <br />they need; or that provide any of these services or supports. <br />10. Criminal justice diversion programs. Support pre-arrest or post-arrest diversion <br />programs, or pre-trial service programs, that connect individuals involved or at risk of <br />becoming involved in the criminal justice system to addiction treatment, recovery <br />support, harm reduction services, primary healthcare, prevention, or other services or <br />supports they need, or that provide any of these services or supports. <br />11. Addiction treatment for incarcerated persons. Support evidence-based addiction <br />treatment, including Medication-Assisted Treatment with at least one FDA-approved <br />opioid agonist, to persons who are incarcerated in jail or prison. <br />12. Reentry Programs. Support programs that connect incarcerated persons to addiction <br />treatment, recovery support, harm reduction services, primary healthcare, or other <br />services or supports they need upon release from jail or prison, or that provide any of <br />these services or supports. <br /> <br />Docusign Envelope ID: C2CD9F79-7C8E-4B6B-8B12-D37C626968D7